Article ; Online: A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
European journal of cancer (Oxford, England : 1990)
2020 Volume 135, Page(s) 130–146
Abstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 ... ...
| Abstract | Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 deaths, including two-third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low- and middle-income countries (LMICs). In this review, we aimed to summarize these international guidelines in accordance with cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumour criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints. |
|---|---|
| MeSH term(s) | Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/transmission ; Coronavirus Infections/virology ; Developing Countries/economics ; Global Burden of Disease ; Humans ; Infection Control/economics ; Infection Control/organization & administration ; Infection Control/standards ; Medical Oncology/economics ; Medical Oncology/organization & administration ; Medical Oncology/standards ; Neoplasms/diagnosis ; Neoplasms/therapy ; Pandemics/prevention & control ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/transmission ; Pneumonia, Viral/virology ; Poverty ; Practice Guidelines as Topic ; SARS-CoV-2 |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-06-08 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 82061-1 |
| ISSN | 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947 |
| ISSN (online) | 1879-0852 |
| ISSN | 0277-5379 ; 0959-8049 ; 0964-1947 |
| DOI | 10.1016/j.ejca.2020.05.015 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 456: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 583: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.